ID   HeLa His10-SUMO-2 K0-Q87R
SY   HeLa His10-SUMO-2 K0
DR   PRIDE; PXD001061
DR   PRIDE; PXD004927
DR   PRIDE; PXD005296
DR   Wikidata; Q54882528
RX   PubMed=25218447;
RX   PubMed=28112733;
CC   Population: African American.
CC   Characteristics: Transfected with a decahistidine (His10) tagged lysine-deficient (K0) and Q87R SUMO2 and GFP separated by an internal ribosome entry site (IRES).
CC   Transfected with: HGNC; 11125; SUMO2 (with p.Lys11Arg, p.Lys32Arg, p.Lys32Arg, p.Lys34Arg, p.Lys41Arg, p.Lys44Arg and p.Gln87Arg).
CC   Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Sumoylated proteins analysis by proteomics.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 6
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C.J., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.O.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.O.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals
RT   co-modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).